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We report a case of a 72-year-old male patient 
with coronary artery disease who was referred to 
our institution for repeated ablation of sustained 
ventricular tachycardia (VT). In 1992 and 2002, the 
patient suffered an anterior myocardial infarction 
which was revascularized with coronary artery by-
pass grafts in 2002. As his left systolic ventricular 
function was severely impaired (ejection fraction 
of 24%), he received an implantable cardioverter 
defibrillator (ICD) for primary prevention of sudden 
cardiac death in 2003. He also suffers from diabe-
tes mellitus, obstructive sleep apnea, peripheral 
vascular disease, and chronic obstructive pulmo-
nary disease. Furthermore, he was on optimal 
pharmacologic therapy for heart failure for many 
years, including beta-blocker (bisoprolol 10 mg), 
Figure 1. A. 12-lead electrocardiogram of the clinical slow ventricular tachycardia with negative QRS in the inferior 
leads and in lead V4–V6, as well as positive QRS in lead V1–V3 suggesting an inferolateral midventricular origin; 
B. Multipolar high-density mapping PentaRay® catheter (Biosense Webster, Diamond Bar, CA) with 5 soft spines con-
sisting of 20 poles (1 mm electrode dimension, 2-6-2 mm spacing size), covering a diameter of 3.5 cm, corresponding 
to an area of over 7 cm2; C. Three-dimensional electroanatomic and bipolar voltage map showing areas of low volt-
age < 0.5 mV representing scar tissue (red areas), as well as point-by-point ablation sites of the critical sites of the 
reentrant circuit (brown points). Three intracardiac electrograms showing late potentials are also depicted.
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angiotensin converting enzyme-inhibitor (ramipril 
2.5 mg), aldosterone inhibitor (aldactone 12.5 mg) 
and diuretics (torasemid 10 mg).
In 2015, the patient was hospitalized due 
to an electrical storm with recurrent sustained 
VTs requiring multiple shocks from his ICD. He 
underwent radiofrequency catheter ablation. In 
addition to his medication with a beta-blocker, an 
antiarrhythmic drug regimen with amiodarone was 
initiated to suppress further ventricular tachyar-
rhythmias [1].
Three months later he was hospitalized again 
because of acute chest pain. A 12-lead electrocar-
diogram (ECG) showed a sustained slow VT with 
a rate of 134 bpm, corresponding to a tachycardia 
cycle length of 448 ms (Fig. 1A). Due to the therapy 
with amiodarone, the VT was slow and below the 
programmed cutoff rate of 176 bpm for VT detec-
tion of the ICD [2]. Therefore, no antitachycardia 
pacing or defibrillation of the ICD occurred. The 
ECG of the VT documented a negative QRS in 
the inferior leads and in lead V4–V6, as well as 
a positive QRS in lead V1–V3 suggesting an in-
ferolateral midventricular origin of the VT [3]. 
The VT could successfully be terminated in the 
emergency room with manual overdrive-pacing via 
Figure 2. Three-dimensional electroanatomic and bipolar voltage maps with intracardiac electrograms showing late 
potentials recorded from the same site with the conventional 3.5 mm tip ablation catheter on Panel A and with the 
multipolar high-density mapping PentaRay® catheter (Biosense Webster, Diamond Bar, CA) with 5 soft spines consist-




Tardu Özkartal et al., Five rays for one ventricular tachycardia
the ICD. A coronary angiography showed patent 
bypass grafts and excluded progression of coronary 
artery disease. After reprogramming the ICD to 
a lower VT detection zone, as well as increasing 
the number and length of anti-tachycardia pacing 
(ATP), the slow VTs were adequately detected 
and successfully terminated after several ATP 
attempts. Since the patient suffered from recur-
rent symptomatic VTs despite ICD reprogram-
ming, he was referred for catheter ablation. At 
the beginning of the electrophysiological study, 
the clinical VT could easily be induced showing 
the clinical QRS morphology. In general anes-
thesia, a bipolar voltage map (Fig. 1C) of the left 
ventricle with a novel multi-polar high-density 
mapping PENTARAY® catheter (Biosense Webster, 
Diamond Bar, CA) was acquired in sinus rhythm 
(Fig. 1B) via transseptal and retrograde catheter 
access sequentially. This high-density mapping 
catheter consists of 20 poles (1 mm electrode 
dimension, 2-6-2 mm spacing size), arranged in 
5 soft spines covering a diameter of 3.5 cm. Together 
with a new software (CONFIDENSETM module) of 
the electrophysiology navigation system CARTO 3 
(Biosense Webster, Diamond Bar, CA), it is able 
to automatically collect electrode locations and 
electrical information (activation and voltage) of 
the tissue in contact in up to 10 different locations 
simultaneously. With this novel mapping catheter 
we were able to collect local voltages of over 
2,500 different locations from the left ventricular 
endocardium within a short period of time. Areas 
of low voltage < 0.5 mV were considered dense 
scar and were marked in red in the voltage map. 
Two different areas of dense scar tissue could be 
identified — one inferolateral midventricular area 
(as suggested by the clinical VT) and one at the 
apex. Surviving myocytes within the dense scar 
lead to a zone of slow conduction and, combined 
with areas of anatomic or functional conduction 
block, give rise to electric re-entry circuits [4–9]. 
At the border zones of these areas, fractionated and 
late potentials were identified by this novel multi-
polar high-density mapping catheter (Fig. 1C), 
while no abnormal signals were seen with the 
conventional 3.5 mm tip ablation catheter (Fig. 2). 
Ablation was applied point-by-point in these distinct 
areas representing a critical pathway of the ven-
tricular reentrant circuit (brown points in Fig. 1C). 
At the end of the procedure the clinical VT could 
not be induced by programmed stimulation with up 
to 4 extrastimuli. The patient could be discharged 
the following day and remained free from ventricu-
lar tachyarrhythmias.
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